Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Himplant is a medical device company that developed the first FDA-cleared silicone implant for aesthetic penile enhancement. The company's flagship product, formerly known as Penuma, is a subcutaneous implant designed to increase the girth and length of the penis for both cosmetic and functional purposes. Developed by urologist Dr. James Elist, the device is a crescent-shaped medical-grade silicone sleeve tailored to the patient's anatomy. Himplant focuses on men's sexual health, providing a surgical solution for conditions such as buried penis or dissatisfaction with penile size. The procedure is performed by specialized surgeons and represents a significant advancement in the field of urological plastic surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Himplant.